Noradrenaline (Norepinephrine) 1:1000 Concentrate For Solution For Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

noradrenaline (norepinephrine) 1:1000 concentrate for solution for infusion

pfizer healthcare ireland - noradrenaline acid tartrate - concentrate for solution for infusion - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine

Noradrenaline (Norepinephrine) 1 mg/ml Concentrate for solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

noradrenaline (norepinephrine) 1 mg/ml concentrate for solution for infusion

pinewood laboratories ltd, - noradrenaline tartrate - concentrate for solution for infusion - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine

NORADRENALINE AGUETTANT 1MGML CONCENTRATE FOR SOLUTION FOR INFUSION Singapore - English - HSA (Health Sciences Authority)

noradrenaline aguettant 1mgml concentrate for solution for infusion

aguettant asia pacific pte. ltd. - noradrenaline tartrate 2mg/ml equiv. noradrenaline - infusion, solution concentrate - noradrenaline tartrate 2mg/ml equiv. noradrenaline 1mg/ml

ADRENALINE-LINK Australia - English - Department of Health (Therapeutic Goods Administration)

adrenaline-link

link medical products pty ltd t/a link pharmaceuticals - adrenaline acid tartrate -

Xylocaine 1% with Adrenaline 1:200,000 New Zealand - English - Medsafe (Medicines Safety Authority)

xylocaine 1% with adrenaline 1:200,000

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline;  ; lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline   lidocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

Marcain 0.25% with adrenaline (epinephrine) 1:400,000 20mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

marcain 0.25% with adrenaline (epinephrine) 1:400,000 20ml injection vial

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 4.5 microgram/ml (equivalent: adrenaline (epinephrine), qty 2.5 microgram/ml); bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.

Adrenaline Injection BP 1 in 1000 New Zealand - English - Medsafe (Medicines Safety Authority)

adrenaline injection bp 1 in 1000

max health limited - adrenaline acid tartrate 1.8 mg/ml equivalent to 1 mg/ml adrenaline;   - solution for injection - 1 mg/ml - active: adrenaline acid tartrate 1.8 mg/ml equivalent to 1 mg/ml adrenaline   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

Aspen Adrenaline New Zealand - English - Medsafe (Medicines Safety Authority)

aspen adrenaline

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 1 mg/ml;   - solution for injection - 1 mg/ml - active: adrenaline 1 mg/ml   excipient: sodium chloride sodium metabisulfite tartaric acid water for injection - latest regulatory activity